Edition:
India

Obalon Therapeutics Inc (OBLN.OQ)

OBLN.OQ on NASDAQ Stock Exchange Global Market

2.93USD
17 Sep 2018
Change (% chg)

$-0.02 (-0.68%)
Prev Close
$2.95
Open
$2.92
Day's High
$3.02
Day's Low
$2.89
Volume
9,629
Avg. Vol
38,187
52-wk High
$10.35
52-wk Low
$1.46

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.49 December 19 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 0 0 0
(3) HOLD 2 2 1 1
(4) UNDERPERFORM 0 0 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6 2.51 3.00 2.10 6.61
Quarter Ending Dec-18 6 2.98 3.40 2.69 7.90
Year Ending Dec-18 6 9.57 10.00 9.20 24.72
Year Ending Dec-19 6 14.91 16.50 14.00 50.17
Earnings (per share)
Quarter Ending Sep-18 6 -0.49 -0.43 -0.61 -0.41
Quarter Ending Dec-18 6 -0.47 -0.36 -0.63 -0.46
Year Ending Dec-18 6 -2.22 -2.01 -2.53 -1.64
Year Ending Dec-19 6 -1.60 -1.21 -2.03 -0.97

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 3.26 2.73 0.52 16.12
Quarter Ending Mar-18 3.46 1.35 2.12 61.14
Quarter Ending Dec-17 3.89 3.69 0.20 5.08
Quarter Ending Sep-17 2.90 2.79 0.11 3.75
Quarter Ending Jun-17 1.72 1.96 0.25 14.31

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 2.51 2.54 2.67 4.04 6.61
Quarter Ending Dec-18 2.98 2.99 3.00 5.02 7.90
Year Ending Dec-18 9.57 9.60 9.71 13.61 24.72
Year Ending Dec-19 14.91 14.81 14.87 21.66 50.17

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 1 1 1
Quarter Ending Dec-18 0 1 0 2
Year Ending Dec-18 0 1 1 1
Year Ending Dec-19 1 0 2 0
Earnings